State Board Of Administration Of Florida Retirement System Kodiak Sciences Inc. Transaction History

State Board Of Administration Of Florida Retirement System

$51.5 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$3.01 - $7.45 $49,081 - $121,479	16,306 New	16,306 $85,000
Q2 2022 Aug 05, 2022	BUY	$5.04 - $9.48 $100 - $189	20 Added 0.12%	16,306 $125,000
Q4 2021 Feb 08, 2022	SELL	$80.85 - $128.49 $38,646 - $61,418	-478 Reduced 2.85%	16,286 $1.38 Million
Q2 2021 Aug 10, 2021	BUY	$77.2 - $126.54 $331,496 - $543,362	4,294 Added 34.43%	16,764 $1.56 Million
Q1 2021 May 10, 2021	SELL	$110.45 - $164.47 $4,418 - $6,578	-40 Reduced 0.32%	12,470 $1.41 Million
Q4 2020 Feb 08, 2021	BUY	$60.78 - $154.03 $40,722 - $103,200	670 Added 5.66%	12,510 $1.84 Million
Q3 2020 Nov 09, 2020	BUY	$45.05 - $59.27 $25,678 - $33,783	570 Added 5.06%	11,840 $701,000
Q1 2020 May 05, 2020	BUY	$38.18 - $73.95 $299,331 - $579,768	7,840 Added 228.57%	11,270 $538,000
Q4 2019 Feb 03, 2020	BUY	$13.9 - $76.65 $47,677 - $262,909	3,430 New	3,430 $247,000

Others Institutions Holding KOD

# of Institutions

Shares Held

39M

Call Options Held

6.5K

Put Options Held

5.8K

Baker Bros. Advisors LP New York, NY

17.3M
Shares

$151 Million
0.48% of portfolio
Black Rock Inc. New York, NY

3.85M
Shares

$33.7 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

1.95M
Shares

$17.1 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

1.69M
Shares

$14.7 Million
0.0% of portfolio
Iconiq Capital, LLC San Francisco, CA

1.02M
Shares

$8.9 Million
0.06% of portfolio

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.

Account